Andere Kunden interessierten sich auch für
![Novel iron chelators for iron overload disease and cancer treatment]( "Novel iron chelators for iron overload disease and cancer treatment")
Novel iron chelators for iron overload disease and cancer treatment51,99 €![The Development of iron chelators for the treatment of cancer]( "The Development of iron chelators for the treatment of cancer")
The Development of iron chelators for the treatment of cancer32,99 €![A Case Study of Iron Deficiency Anemia in University Students]( "A Case Study of Iron Deficiency Anemia in University Students")
A Case Study of Iron Deficiency Anemia in University Students23,99 €![The molecular effects of anthracyclines on iron metabolism]( "The molecular effects of anthracyclines on iron metabolism")
The molecular effects of anthracyclines on iron metabolism32,99 €![Comparative study of Safety of Iron Salts in Anemia during Pregnancy]( "Comparative study of Safety of Iron Salts in Anemia during Pregnancy")
Comparative study of Safety of Iron Salts in Anemia during Pregnancy38,99 €![Toxicity Study Of Two Iron Containing Bhasmas]( "Toxicity Study Of Two Iron Containing Bhasmas")
Toxicity Study Of Two Iron Containing Bhasmas44,99 €![Human Tumour Xenografts in Anticancer Drug Development]( "Human Tumour Xenografts in Anticancer Drug Development")
Human Tumour Xenografts in Anticancer Drug Development125,99 €
Previous studies demonstrated that HDpT chelators have potent anti-tumour activity. We have now designed and generated two new groups of chelators, HBpT and HNBpT. Comparing the three series of chelators, the HBpT analogues displayed highest anti- proliferative efficacy against SK-N-MC neuroepithelioma cells and was greater than other well known chelators (DFO, Triapine® and 311). Three analogues of the HBpT series displayed much greater anti-proliferative activity against SK-N-MC cells than normal MRC-5 fibroblasts, indicating their selectivity against tumour cells. Structure-activity relationships examination demonstrated that lipophilicity and redox cycling activity were important factors in generating potent chelators. Redox activity determined by ascorbate oxidation and benzoate hydroxylation assays showed that the HBpT ligands were the most active chelators. Microarray studies using DFO and HDp44mT, demonstrated up- regulation of the gene in cell cycle arrest, while genes in cancer progression were down-regulated. The current studies have identified a novel group of chelators with the greatest activity of all chelators previously prepared in our lab.